Lacosamide and blood‑pressure changes
Lacosamide is not a vasodilator or a hypertension‑medication, so it does not routinely raise or lower blood pressure in the way that beta‑blockers, diuretics, or calcium‑channel blockers do. In most people it is hemodynamically neutral. However, there are a few clinical situations in which you should keep an eye on BP:
| Situation | What to watch for | Typical threshold | Why it matters |
|-----------|-------------------|-------------------|----------------|
| Orthostatic/positional change (especially in elderly or patients on antihypertensives) | A drop in systolic BP of ≥ 20 mm Hg or diastolic BP of ≥ 10 mm Hg when moving from supine/lying to standing | ≥ 20 / 10 mm Hg | Can cause dizziness, falls, or syncope – a common side‑effect of many anticonvulsants. |
| Baseline hypertension | A sudden rise in systolic BP of ≥ 20 mm Hg or diastolic BP of ≥ 10 mm Hg compared to the patient’s usual readings | ≥ 20 / 10 mm Hg | Can worsen existing hypertension or increase cardiovascular risk. |
| General vigilance | Any sudden or sustained change in BP (↑ or ↓) >10–20 mm Hg that is unexplained | >10–20 mm Hg | May indicate a drug‑related effect (e.g., volume shifts, neurogenic changes) that requires dose adjustment or further evaluation. |
How to monitor
1. Baseline – Measure BP twice (lying and seated) before starting lacosamide.
2. Early on – Re‑check after 1–2 weeks, and again at 4–6 weeks if the patient is on a titration schedule.
3. During titration – Check BP after each dose increase.
4. On‑going – Routine BP checks (seated) at each clinic visit or when the patient reports dizziness, syncope, or other symptoms.
5. Orthostatic BP – For high‑risk patients (older adults, those with pre‑existing HTN, or on antihypertensives), measure BP after 1 min and 3 min of standing.
What to do if a change is seen
| BP change | Action |
|-----------|--------|
| Drop ≥ 20 / 10 mm Hg (orthostatic) | Consider slowing the titration rate, evaluating for other causes (volume depletion, dehydration, medications), and discussing positional changes (e.g., sit‑to‑stand slowly). |
| Rise ≥ 20 / 10 mm Hg | Check for other hypertensive triggers (diet, stress, other meds). If the increase persists, consider reducing lacosamide or switching therapy. |
| Any unexplained fluctuation > 10–20 mm Hg | Repeat BP, review medication list, consider cardiac evaluation (ECG for QTc), and consult a cardiologist if needed. |
Key take‑away
- Lacosamide is usually BP‑neutral, but in susceptible patients you may observe orthostatic hypotension or a small rise in BP.
- Thresholds of ≥ 20 mm Hg systolic or ≥ 10 mm Hg diastolic for orthostatic changes and similar absolute changes for rises are the most clinically useful signals.
- Prompt monitoring and dose adjustment can prevent symptoms such as dizziness, falls, or cardiovascular complications.
Bottom line: Keep a low threshold for measuring BP in patients starting lacosamide, particularly if they have hypertension, are on antihypertensives, or are elderly. A sudden orthostatic fall of ≥ 20 / 10 mm Hg or a comparable rise is a red flag that may warrant dose reconsideration.